The investigation, published March 25, was prompted by a complaint from a nurse alleging that she was denied participation in the Indiana State Nursing Assistance Program because she takes medication to treat opioid use disorder.
Investigators found the board violated the Americans with Disabilities Act by prohibiting nurses taking this medication to participate in the program, which rehabilitates and monitors nurses with substance use disorders, and is often required to maintain an active license or have one reinstated.
A letter detailing the findings asked the board to work with the Justice Department to resolve the identified civil rights violations.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
